Novel Oligomeric Fluoropyrimidines and Their Efficacy for the Treatment of Colorectal Carcinoma Independent of p53 Mutation
Electronic Theses and Dissertations
Item Files
Item Details
- title
- Novel Oligomeric Fluoropyrimidines and Their Efficacy for the Treatment of Colorectal Carcinoma Independent of p53 Mutation
- author
- Dominijanni, Anthony
- abstract
- The treatment of advanced stage colorectal carcinoma (CRC) is rarely achieved with today’s standard of care, including 5-fluorouracil (5-FU). Resistance to 5-FU is unfortunately frequent in CRC partially due to the dependency 5-FU displays towards normal p53 function, a tumor suppressor protein that is commonly mutated in advanced CRC. In addition to the relatively low success rate of 5-FU in aggressive CRC, 5-FU treatment also causes systemic toxicity, particularly to the GI-tract. The presented studies aimed to demonstrate that our novel oligomeric fluoropyrimidines are able to overcome these limitations of 5-FU in vivo. The results indicate that F10 and other fluoropyrimidines showed little-to-no p53 dependency in in vivo xenografts. While F10 displayed the same p53 independency in vitro when assessing cell viability and caspase activation, 5-FU showed a dependency on normal p53 function in vitro while further studies are needed to conclude in vivo p53-dependency. The results also indicate that these fluoropyrimidines are viable treatments for CRC by showing tumor suppression in xenograft models and in a more realistic orthotopic model. Systemic toxicity was not seen during novel fluoropyrimidine treatment in terms of GI-tract villi or crypt shortening, whereas 5-FU caused major toxicity, both short-term and long-term. These findings indicate that the limitations of 5-FU are eliminated by our fluoropyrimidines in a mouse model and may possibly transition to the clinical setting.
- subject
- colorectal carcinoma
- fluoropyrimidines
- contributor
- Gmeiner, William (committee chair)
- Dubey, Purnima (committee member)
- Alli, Elizabeth (committee member)
- date
- 2017-08-22T08:35:25Z (accessioned)
- 2019-08-18T08:30:11Z (available)
- 2017 (issued)
- degree
- Cancer Biology (discipline)
- embargo
- 2019-08-18 (terms)
- identifier
- http://hdl.handle.net/10339/86346 (uri)
- language
- en (iso)
- publisher
- Wake Forest University
- type
- Thesis